Boxford, MA, United States of America

Ezra Schildkraut

This inventor holds 3 USPTO granted patents. Top assignees: New England Biolabs, Inc., Bank of America, N.a., as Administrative Agent. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ezra Schildkraut. Retrieved from https://idiyas.com/inventor/ezra-schildkraut

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Cerillos, NM (US) (2019)
  • Boxford, MA (US) (2022)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Ezra Schildkraut

Introduction

Ezra Schildkraut is a notable inventor based in Boxford, MA (US). He has made significant contributions to the field of synthetic RNA polynucleotides, holding 3 patents that showcase his innovative work.

Latest Patents

Schildkraut's latest patents focus on compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides. These patents provide methods for forming a single RNA polynucleotide from a plurality of DNA oligonucleotides in a single reaction chamber using combined reagents in a single-step reaction. The process involves combining DNA polymerase, RNA polymerase, and single-stranded (ss) DNA oligonucleotides, where each DNA oligonucleotide contains one or more sequence modules. One sequence module in the first ss DNA oligonucleotide is complementary to a sequence module at the 3' end of the second ss DNA oligonucleotide. Additionally, a second module on the first ss DNA oligonucleotide serves as an RNA polymerase promoter sequence, leading to the formation of a single RNA polynucleotide, excluding the RNA promoter sequence, derived from the first and second DNA oligonucleotides.

Career Highlights

Ezra Schildkraut is currently employed at New England Biolabs, Inc., where he continues to advance his research and development in the field of molecular biology. His work has been instrumental in enhancing the understanding and application of synthetic RNA technologies.

Collaborations

Schildkraut has collaborated with notable colleagues, including G Brett Robb and Isaac B Meek, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ezra Schildkraut's contributions to the field of synthetic RNA polynucleotides reflect his dedication to advancing scientific knowledge and technology. His innovative patents and collaborative efforts position him as a key figure in molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…